Jedrzejczak W W, Pojda Z
Arch Immunol Ther Exp (Warsz). 1987;35(1):71-8.
The preparation of single cell suspension from human fetal liver is described. The technique is based on pressing the liver through wire mesh followed by repeated aspiration into a syringe through needles of decreasing internal diameter. Subsequently, the cell suspension is depleted of cell debris by a "triple medium sedimentation procedure" without net loss of hemopoietic cells. Following centrifugation and resuspension the preparation is ready for either transplantation or storage. About 2 and 11 X 10(9) cells were obtained per liver depending on the age of fetus in the range of 16 and 24 weeks of gestation in three representative preparations. The cell suspension contained comparable numbers of hemopoietic progenitors to the adult bone marrow suspension as assayed using plasma clot diffusion chamber technique.
本文描述了从人胎肝制备单细胞悬液的方法。该技术是先将肝脏通过金属丝网挤压,然后通过内径逐渐减小的针头反复吸入注射器。随后,通过“三重介质沉降程序”去除细胞碎片,而造血细胞无净损失。离心和重悬后,制备物即可用于移植或储存。在三个代表性的制备物中,根据妊娠16至24周胎儿的年龄,每个肝脏大约可获得2×10⁹和11×10⁹个细胞。使用血浆凝块扩散室技术检测发现,该细胞悬液中造血祖细胞的数量与成人骨髓悬液相当。